Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 29;21(1):33-38.
doi: 10.2478/bjmg-2018-0007. eCollection 2018 Jun.

ADRB2 Gene Polymorphisms and Salbutamol Responsiveness in Serbian Children with Asthma

N Jovicic  1 , T Babic  2 , S Dragicevic  2 , B Nestorovic  1   3 , A Nikolic  2
Affiliations

ADRB2 Gene Polymorphisms and Salbutamol Responsiveness in Serbian Children with Asthma

N Jovicic et al. Balkan J Med Genet. .

Abstract

Inhaled β2 adrenergic receptor (β2-AR) agonists are the mainstay of asthma therapy. The β2-AR protein is encoded by the ADRB2 gene and variants within this gene can have significant consequences for modulating the response to asthma therapy. This cross-sectional study performed at the University Children's Hospital in Belgrade, included 54 children with asthma. The subjects were genotyped for ADRB2 +46A>G (Arg16Gly, rs1042713) and +79C>G (Gln27Glu, rs 1042714) polymorphisms and the association with asthma severity and response to inhaled salbutamol was examined. In Serbian asthmatic children, allele +46A was detected with a frequency of 41.7% and allele +79G was detected with a frequency of 23.1%. Allele +46G was found to be associated with a better response to inhaled salbutamol (p <0.05) and with mild form of asthma (p <0.05). Polymorphism ADRB2 +46A>G may be a determinant of asthma severity and response to salbutamol in children with asthma. We did not find any association of +79C>G polymorphisms with the asthma severity and bronchodilator response to inhaled salbutamol. The results of this study can be potentially useful for personalization of asthma treatment.

Keywords: ADRB2 gene; Asthma; Bronchodilatator response; Polymorphism.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Pharmacogenetics of Pediatric Asthma: Current Perspectives.
    Perez-Garcia J, Espuela-Ortiz A, Lorenzo-Diaz F, Pino-Yanes M. Perez-Garcia J, et al. Pharmgenomics Pers Med. 2020 Mar 18;13:89-103. doi: 10.2147/PGPM.S201276. eCollection 2020. Pharmgenomics Pers Med. 2020. PMID: 32256100 Free PMC article. Review.

References

    1. Global initiative for asthma. Global strategy for asthma management and prevention. 2016. www.ginasthma.org Available from.
    1. Baren JM, Zorc JJ. Contemporary approach to the emergency department management of pediatric asthma. Emerg Med Clin North Am. 2002;20(1):115. –. - PubMed
    1. Martin AC, Zhang G, Rueter K, Geelhoed G, Goldblatt J, Laing I. et al. β2-Adrenoceptor polymorphisms predict response to β2-agonists in children with acute asthma. J Asthma. 2008;45(5):383. –. - PubMed
    1. Barnes KC. Genetic studies of the etiology of asthma. Proc Am Thorac Soc. 2011;8(4):143. –. - PMC - PubMed
    1. Contopoulos-Ioannidis DG, Manoli EN, Ioannidis JP. Meta-analysis of the association of β2-adrenergic receptor polymorphisms with asthma phenotypes. J Allergy Clin Immunol. 2005;115(5):963. –. - PubMed

LinkOut - more resources